Wang et al. (2021) demonstrated that in docetaxel-resistant PCa cells and tissues, the lncRNA OGFRP1 was highly expressed, additionally,it was possible to enhance these cells’ susceptibility to docetaxel and paclitaxel both in vitro and in vivo by suppressing OGFRP1 via the upregulation of miR149-5p and the subsequent downregulation of IL-6. The gene discussed is OGFRP1; the disease is posterior cortical atrophy.